Literature DB >> 8034756

Inhibition of murine splenic T lymphocyte proliferation by 2-deoxy-D-glucose-induced metabolic stress.

E S Miller1, J C Klinger, C Akin, D A Koebel, G Sonnenfeld.   

Abstract

Female Swiss-Webster mice were injected with the glucose analogue 2-deoxy-D-glucose (2-DG), which when administered to rodents induces acute periods of metabolic stress. A single or multiple injections of 2-DG invoked a stress response, as evidenced by increases in serum corticosterone levels. The influence of this metabolic stressor on the blastogenic potential of splenic T lymphocytes was then examined. It was found that one, two, or three injections of 2-DG resulted in depressed T cell proliferative responses, with an attenuation of the effect occurring by the fifth injection. The 2-DG-induced inhibition of T cell proliferation was not attributable to 2-DG-induced cytolysis, as in vitro incubation of naive T cells with varying concentrations of 2-DG did not result in a reduction in cell number or viability, and flow cytometric analysis demonstrated that percentages of CD3, CD4, and CD8 splenic T cells were not altered as a result of 2-DG-induced stress. Incubating naive T cells in varying concentrations of 2-DG resulted in a dose-dependent inhibition of T cell blastogenic potential. Following in vivo exposure to 2-DG, T cell proliferation did not return to normal levels until 3 days after the cessation of 2-DG injections. Administering the beta-adrenergic receptor antagonist propranolol did not reverse the inhibited lymphoproliferation in 2-DG-treated mice. The inhibition in T cell proliferation was not observed, however, in mice that had been adrenalectomized or hypophysectomized and injected with 2-DG.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; Non-NASA Center

Mesh:

Substances:

Year:  1994        PMID: 8034756     DOI: 10.1016/0165-5728(94)90110-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  HPLC and LC-MS analysis of sinomenine and its application in pharmacokinetic studies in rats.

Authors:  Li-hong Long; Peng-fei Wu; Xiang-long Chen; Zui Zhang; Yu Chen; Yi-yong Li; You Jin; Jian-guo Chen; Fang Wang
Journal:  Acta Pharmacol Sin       Date:  2010-09-27       Impact factor: 6.150

Review 2.  Metabolic reprogramming and metabolic dependency in T cells.

Authors:  Ruoning Wang; Douglas R Green
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

3.  Dual proteolytic pathways govern glycolysis and immune competence.

Authors:  Wei Lu; Yu Zhang; David O McDonald; Huie Jing; Bernadette Carroll; Nic Robertson; Qian Zhang; Helen Griffin; Sharon Sanderson; Jeremy H Lakey; Neil V Morgan; Louise N Reynard; Lixin Zheng; Heardley M Murdock; Stuart E Turvey; Scott J Hackett; Tim Prestidge; Julie M Hall; Andrew J Cant; Helen F Matthews; Mauro F Santibanez Koref; Anna Katharina Simon; Viktor I Korolchuk; Michael J Lenardo; Sophie Hambleton; Helen C Su
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

4.  III. Cellular ultrastructures in situ as key to understanding tumor energy metabolism: biological significance of the Warburg effect.

Authors:  Halina Witkiewicz; Phil Oh; Jan E Schnitzer
Journal:  F1000Res       Date:  2013-01-10

5.  Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells.

Authors:  Yilin Cao; Jeffrey C Rathmell; Andrew N Macintyre
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.